<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04183959</url>
  </required_header>
  <id_info>
    <org_study_id>MD-53-2019</org_study_id>
    <nct_id>NCT04183959</nct_id>
  </id_info>
  <brief_title>Intubating Video Stylet Versus Fiberoptic Intubating Bronchoscope.</brief_title>
  <official_title>Intubating Video Stylet Versus Fiberoptic Intubating Bronchoscope. A Randomised Comparative Study for Intubation in Lateral Position.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Theodor Bilharz Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      the video stylet (VS), it is considered one of the newer devices in this category. It is a&#xD;
      portable device with liquid crystal-display module screen for visualization of vocal cords.&#xD;
      It is considered an alternative to the flexible fiberoptic endoscope especially in the&#xD;
      developing countries where the device cost is the main limiting factor. It has many benefits&#xD;
      such as being light weight, easy to clean, durable, chargeable, less expensive and reusable.&#xD;
      However newer video stylet devices have not been formally evaluated for tracheal intubation&#xD;
      in case of laterally positioned patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Following approval from Ethics and Research Committee of Theodor Bilharz Research Institute,&#xD;
      the study protocol will be explained to the patients after taking their consent.&#xD;
&#xD;
      Upon arrival to the operating room, a 20 G cannula will be sited intravenously and infusion&#xD;
      of Ringer's solution will be started. Intravenous midazolam in a dose of 0.05 mg/ Kg will be&#xD;
      given. Then, a five-lead electrocardiogram (GE-Datex Ohmeda 5 lead ECG cable), a pulse&#xD;
      oximeter (GE- Datex Ohmeda adult finger spO2 sensor) and a non-invasive blood pressure&#xD;
      monitor (GE-Datex Ohmeda NIBP cuff, adult double tube with bag) will be attached to the&#xD;
      patient.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 3, 2019</start_date>
  <completion_date type="Actual">July 22, 2020</completion_date>
  <primary_completion_date type="Actual">June 16, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intubation time</measure>
    <time_frame>up to 1 hour</time_frame>
    <description>(defined as the time when the device is introduced into the mouth till it is removed after the confirmation of correct placement of ETT by the appearance of an optimal waveform on the capnograph</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intubation success rate</measure>
    <time_frame>up to 1 hour</time_frame>
    <description>Intubation success rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of intubation attempts</measure>
    <time_frame>up to 1 hour</time_frame>
    <description>Number of intubation attempts</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemodynamic stability</measure>
    <time_frame>up to 1 hour</time_frame>
    <description>assessed based on MAP and HR, which will be measured at the following time intervals: before induction of anesthesia at baseline (BA), after induction of anesthesia but before tracheal intubation (T1), and immediately after successful intubation (T2)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Intubating Video Stylet</condition>
  <arm_group>
    <arm_group_label>Group- video stylet intubation (VS)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>trachea will be intubated using laryngoscopic assisted video stylet device in lateral position</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group- fiberoptic intubation (FO)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>: intubation will be done using fiberoptic device by the same anesthesiologist in lateral position</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>video stylet</intervention_name>
    <description>trachea will be intubated using laryngoscopic assisted video stylet device in lateral position</description>
    <arm_group_label>Group- video stylet intubation (VS)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>fiberoptic</intervention_name>
    <description>intubation will be done using fiberoptic device by the same anesthesiologist in lateral position</description>
    <arm_group_label>Group- fiberoptic intubation (FO)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient age 18- 60 years.&#xD;
&#xD;
          -  Both sexes&#xD;
&#xD;
          -  American Society of Anesthesiologists(ASA) physical status classes I and II.&#xD;
&#xD;
          -  Non-obese patients ( BMI &lt;35)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Difficult intubation; mallampati 3 or 4, Dental abnormalities, Cervical spine&#xD;
             pathology that limits neck mobility , obese patients ( BMI â‰¥ 35) .&#xD;
&#xD;
          -  Cardiovascular disease, hypertensive patients, Pregnant and nursing women, High risk&#xD;
             of pulmonary aspiration.&#xD;
&#xD;
          -  Patients at risk of bleeding either impaired bleeding profile or receiving&#xD;
             anticoagulants&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nesrine Elrefai, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor of Anaesthesia, surgical ICU &amp;Pain management</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sohaila Omar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor of Anaesthesia and surgical ICU</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed Hussien, MD</last_name>
    <role>Study Director</role>
    <affiliation>Lecturer of Anaesthesia and surgical ICU</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Medicine, Cairo University.</name>
      <address>
        <city>Cairo</city>
        <zip>11451</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>November 29, 2019</study_first_submitted>
  <study_first_submitted_qc>December 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2019</study_first_posted>
  <last_update_submitted>July 28, 2020</last_update_submitted>
  <last_update_submitted_qc>July 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Amr Samir Wahdan</investigator_full_name>
    <investigator_title>Lecturer of Anesthesia, Pain management and Surgical ICU</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Still working</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

